Infliximab is a plausible alternative for neurologic complications of Behçet disease

Burcu Zeydan, Ugur Uygunoglu, Sabahattin Saip, Onat N. Demirci, Emire Seyahi, Serdal Ugurlu, Vedat Hamuryudan, Aksel Siva, Orhun H. Kantarci

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint Dive into the research topics of 'Infliximab is a plausible alternative for neurologic complications of Behçet disease'. Together they form a unique fingerprint.

Medicine & Life Sciences